Clinical Trials · NCT07191873

Tirzepatide in Idiopathic Intracranial Hypertension Trial

Name: Tirzepatide in Idiopathic Intracranial Hypertension Trial
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 4Tirzepatide

Phase: Phase 4
Recruitment status: Recruiting
Sponsor: Duke University
Enrollment: 60
Start date: Aug 2026
Locations: 1 site, United States
Primary endpoint: Change in intracranial pressure in Idiopathic Intracranial Hypertension (IIH) patients

View Tirzepatide compound reference